Shengbin Pei

机构：Tianjin University, Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center, National Clinical Research, Jiangsu Province Hospital, Nanjing Medical University

发表论文 41 篇 · 总被引 716 次 · h-index 14

代表论文

• Germinal center B-cell subgroups in the tumor microenvironment cannot be overlooked: Their involvement in prognosis, immunotherapy response, and treatment resistance in head and neck squamous carcinoma (2024 · Heliyon · 被引 33)
• Purine metabolism in lung adenocarcinoma: A single‐cell analysis revealing prognostic and immunotherapeutic insights (2024 · Journal of Cellular and Molecular Medicine · 被引 30)
• A new 4-gene-based prognostic model accurately predicts breast cancer prognosis and immunotherapy response by integrating WGCNA and bioinformatics analysis (2024 · Frontiers in Immunology · 被引 17)
• Single-cell sequencing unveils mitophagy-related prognostic model for triple-negative breast cancer (2024 · Frontiers in Immunology · 被引 15)
• Pan cancer research reveals the role of PTGDS in tumor suppression and immune regulation (2025 · npj Precision Oncology · 被引 12)
• Advancing predictive markers in lung adenocarcinoma: A machine learning‐based immunotherapy prognostic prediction signature (2024 · Environmental Toxicology · 被引 9)